PuSH - Publikationsserver des Helmholtz Zentrums München

216 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Ashton, M.P.* et al.: Association of dendritic cell signatures with autoimmune inflammation revealed by single-cell profiling. Arthritis Rheum. 71, 817-828 (2019)
2.
Eugster, A.* et al.: Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes. Diabetologia 62, 805-810 (2019)
3.
Hippich, M. et al.: Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families. Diabetes 68, 847-857 (2019)
4.
Hoffmann, V. et al.: Landmark models to define the age-adjusted risk of developing stage 1 type 1 diabetes across childhood and adolescence. BMC Med. 17:125 (2019)
5.
Jacobsen, L.M.* et al.: Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children. Pediatr. Diabetes 20, 263-270 (2019)
6.
Krischer, J.P.* et al.: Predicting islet cell autoimmunity and type 1 diabetes: An 8-year teddy study progress report. Diabetes Care 42, 1051-1060 (2019)
7.
Laimighofer, M. et al.: Common patterns of gene regulation associated with Cesarean section and the development of islet autoimmunity - indications of immune cell activation. Sci. Rep. 9:6250 (2019)
8.
Peplow, C. et al.: Blood draws up to 3% of blood volume in clinical trials are safe in children. Acta Paediatr. 108, 940-944 (2019)
9.
Silvis, K.* et al.: Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study. Pediatr. Diabetes 20, 86-92 (2019)
10.
Ungethüm, K. et al.: Physical activity is associated with lower insulin and C-peptide during glucose challenge in children and adolescents with family background of diabetes. Diabetic Med. 36, 366-375 (2019)
11.
Winkler, C. et al.: Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results. Pediatr. Diabetes, accepted (2019)
12.
Winkler, C. et al.: Age, HLA, and sex define a marked risk of organ-specific autoimmunity in first-degree relatives of patients with type 1 diabetes. Diabetes Care, accepted (2019)
13.
Ziegler, A.-G. et al.: Screening for asymptomatic β-cell autoimmunity in young children. Lancet Child Adolesc. Health 3, 288-290 (2019)
14.
Ziegler, A.-G. et al.: Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. BMJ Open 9:e028578 (2019)
15.
Achenbach, P. et al.: Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12. Diabetologia 61, 1644-1649 (2018)
16.
Beyerlein, A. et al.: Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: Results from the prospective TEDDY study. J. Med. Genet., accepted (2018)
17.
Bonifacio, E.* et al.: Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children. PLoS Med. 15:e1002548 (2018)
18.
Couper, J.J.* et al.: ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr. Diabetes 19, 20-27 (2018)
19.
Endesfelder, D. et al.: Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119-130 (2018)
20.
Frohnert, B.I.* et al.: Prediction of type 1 diabetes using a genetic risk model in the Diabetes Autoimmunity Study in the Young. Pediatr. Diabetes 19, 277-283 (2018)